|
deoxyribopyrimidine endonucleosidase
|
C036401 |
|
|
SB 223956
|
C496617 |
|
|
glutamate aminotransferase
|
C036402 |
|
|
VAV1 protein, human
|
C496618 |
|
|
ICI 154129
|
C036405 |
|
|
oxymorphamine
|
C036406 |
|
|
quartromicin A3
|
C457020 |
|
|
17-cyano-5,16-androstadien-3 beta-ol-3-acetate
|
C036407 |
|
|
quartromicin
|
C457021 |
|
|
5,12-dimethylchrysene
|
C036408 |
|
|
N-nitroso-bis(4,4,4-trifluorobutyl)amine
|
C036409 |
|
|
17-(cyclopropylmethyl)-4,5 alpha-epoxy-6 beta,21-epoxymethano-3-hydroxy-6,14-endoethenomorphinan-7 alpha-(N-phenethyl)carboxamide
|
C496610 |
|
|
Quinolines
|
D011804 |
|
|
Phenylhomophthalimide
|
C496608 |
|
|
Quinolinic Acids
|
D011805 |
[Dicarboxylic acids with a PYRIDINE backbone. Quinolinic Acids are downstream products of the KYNURENINE pathway which metabolize amino acid TRYPTOPHAN.
] |
|
2-anilino-4-(1H-pyrrol-3-yl) pyrimidine
|
C496609 |
|
|
Quinolinium Compounds
|
D011806 |
|
|
Quinolizines
|
D011807 |
|
|
Quinone Reductases
|
D011808 |
[NAD(P)H:(quinone acceptor) oxidoreductases. A family that includes three enzymes which are distinguished by their sensitivity to various inhibitors. EC 1.6.99.2 (NAD(P)H DEHYDROGENASE (QUINONE);) is a flavoprotein which reduces various quinones in the presence of NADH or NADPH and is inhibited by dicoumarol. EC 1.6.99.5 (NADH dehydrogenase (quinone)) requires NADH, is inhibited by AMP and 2,4-dinitrophenol but not by dicoumarol or folic acid derivatives. EC 1.6.99.6 (NADPH dehydrogenase (quinone)) requires NADPH and is inhibited by dicoumarol and folic acid derivatives but not by 2,4-dinitrophenol.
] |
|
Quinones
|
D011809 |
[Hydrocarbon rings which contain two ketone moieties in any position. They can be substituted in any position except at the ketone groups.
] |
